ECI Conference on Microbial Engineering Webinar
Webinar Presentations Available Here
January 26, 2021
10:00 – 12:30 (New York) – 15:00 – 17:30 (London)
Our community has made extraordinary progress toward developing a number of promising vaccine candidates to provide protection against COVID-19 disease. Because of the pandemic, we have postponed the face-to-face Microbial Engineering II conference to September 19-23, 2021 in Albufeira, Portugal. To keep the community up to date, this webinar will focus on a variety of programs based either on microbial platforms or cell free synthesis. Each speaker will entertain participant questions.
Confirmed Speakers
John Liddell, CPI, UK
“Microbial technology supporting
COVID-19 vaccine development”
Kathrin Jansen, Pfizer, USA
“Learnings from the development of a
COVID-19 RNA vaccine”
Vikram Paradkar, Biological E, India
“Development of COVID-19 vaccine based on receptor binding domain from
spike protein of SARS-CoV-2”
Ronen Tchelet, Dyadic International, USA
“C1- A a low cost production platform to combat COVID-19 pandemic”.
Andrey Zarur, Greenlight Biosciences, USA
“Scaling cell free synthesis of mRNA to enable global herd immunity through COVID-19 vaccine.
Robert Juba Jr., Inovio, USA
“Leveraging a plasmid DNA platform
for COVID-19 vaccine development”
Mark Bodmer, EVELO, USA
“From worms to the small intestinal axis – a new approach to resolving systemic inflammation caused by COVID-19”.